{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T22:37:54Z","timestamp":1783723074097,"version":"3.55.0"},"reference-count":109,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.path.2021.05.011","type":"journal-article","created":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T17:52:41Z","timestamp":1628272361000},"page":"493-506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Molecular Pathology of Thyroid Tumors"],"prefix":"10.1016","volume":"14","author":[{"given":"Juan C.","family":"Hernandez-Prera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.path.2021.05.011_bib1","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","year":"2014","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.path.2021.05.011_bib2","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.beem.2008.09.019","article-title":"Epidemiology of thyroid nodules","volume":"22","author":"Dean","year":"2008","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.path.2021.05.011_bib3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1365-2362.2009.02162.x","article-title":"Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination","volume":"39","author":"Guth","year":"2009","journal-title":"Eur J Clin Invest"},{"issue":"8","key":"10.1016\/j.path.2021.05.011_bib4","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1056\/NEJM199302253280807","article-title":"Management of a solitary thyroid nodule","volume":"328","author":"Mazzaferri","year":"1993","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.path.2021.05.011_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"issue":"5","key":"10.1016\/j.path.2021.05.011_bib6","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1309\/AJCPPHLWMI3JV4LA","article-title":"The Bethesda system for reporting thyroid cytopathology","volume":"132","author":"Cibas","year":"2009","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"10.1016\/j.path.2021.05.011_bib7","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1089\/thy.2017.0500","article-title":"The 2017 Bethesda system for reporting thyroid cytopathology","volume":"27","author":"Cibas","year":"2017","journal-title":"Thyroid"},{"issue":"4","key":"10.1016\/j.path.2021.05.011_bib8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000339959","article-title":"The Bethesda system for reporting thyroid cytopathology: a meta-analysis","volume":"56","author":"Bongiovanni","year":"2012","journal-title":"Acta Cytol"},{"issue":"5","key":"10.1016\/j.path.2021.05.011_bib9","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/cncr.30708","article-title":"Molecular testing for thyroid nodules: review and current state","volume":"124","author":"Roth","year":"2018","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.path.2021.05.011_bib10","doi-asserted-by":"crossref","first-page":"979","DOI":"10.4158\/EP171805.RA","article-title":"Role of molecular markers in thyroid nodule management: then and now","volume":"23","author":"Nikiforov","year":"2017","journal-title":"Endocr Pract"},{"issue":"3","key":"10.1016\/j.path.2021.05.011_bib11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1530\/ERC-16-0512","article-title":"Evaluation of ThyroSeq v2 performance in thyroid nodules with indeterminate cytology","volume":"24","author":"Valderrabano","year":"2017","journal-title":"Endocr Relat Cancer"},{"issue":"7","key":"10.1016\/j.path.2021.05.011_bib12","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrm2438","article-title":"Ras oncogenes: split personalities","volume":"9","author":"Karnoub","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"10.1016\/j.path.2021.05.011_bib13","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/0092-8674(92)90076-O","article-title":"ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK","volume":"68","author":"Wood","year":"1992","journal-title":"Cell"},{"issue":"6490","key":"10.1016\/j.path.2021.05.011_bib14","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/370527a0","article-title":"Phosphatidylinositol-3-OH kinase as a direct target of Ras","volume":"370","author":"Rodriguez-Viciana","year":"1994","journal-title":"Nature"},{"issue":"5979","key":"10.1016\/j.path.2021.05.011_bib15","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/310644a0","article-title":"Comparative biochemical properties of normal and activated human ras p21 protein","volume":"310","author":"McGrath","year":"1984","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.path.2021.05.011_bib16","first-page":"403","article-title":"Detection of activated ras oncogenes in human thyroid carcinomas","volume":"2","author":"Suarez","year":"1988","journal-title":"Oncogene"},{"issue":"16","key":"10.1016\/j.path.2021.05.011_bib17","first-page":"4459","article-title":"Activated ras oncogenes in human thyroid cancers","volume":"48","author":"Lemoine","year":"1988","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.path.2021.05.011_bib18","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2002-021186","article-title":"Specific pattern of RAS oncogene mutations in follicular thyroid tumors","volume":"88","author":"Vasko","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.path.2021.05.011_bib19","first-page":"159","article-title":"High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis","volume":"4","author":"Lemoine","year":"1989","journal-title":"Oncogene"},{"key":"10.1016\/j.path.2021.05.011_bib20","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.onc.1203399","article-title":"RAS oncogene activation induces proliferation in normal human thyroid epithelial cells without loss of differentiation","volume":"19","author":"Gire","year":"2000","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.path.2021.05.011_bib21","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1158\/0008-5472.CAN-09-0024","article-title":"Oncogenic Kras requires simultaneous PI3K signaling to induce ERK activation and transform thyroid epithelial cells in\u00a0vivo","volume":"69","author":"Miller","year":"2009","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.path.2021.05.011_bib22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1089\/thy.2019.0650","article-title":"Molecular determinants of thyroid nodules with indeterminate cytology and RAS mutations","volume":"31","author":"Hernandez-Prera","year":"2021","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.path.2021.05.011_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.surg.2018.04.062","article-title":"Interinstitutional variation in predictive value of the ThyroSeq v2 genomic classifier for cytologically indeterminate thyroid nodules","volume":"165","author":"Marcadis","year":"2019","journal-title":"Surgery"},{"issue":"8","key":"10.1016\/j.path.2021.05.011_bib24","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1634\/theoncologist.2013-0072","article-title":"RAS mutations in thyroid cancer","volume":"18","author":"Howell","year":"2013","journal-title":"Oncologist"},{"issue":"6","key":"10.1016\/j.path.2021.05.011_bib25","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1089\/thy.2017.0635","article-title":"Heterogeneity in positive predictive value of RAS mutations in cytologically indeterminate thyroid nodules","volume":"28","author":"Nabhan","year":"2018","journal-title":"Thyroid"},{"issue":"4","key":"10.1016\/j.path.2021.05.011_bib26","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1089\/thy.2019.0116","article-title":"Utilities of RAS mutations in preoperative fine needle biopsies for decision making for thyroid nodule management: results from a single-center prospective cohort","volume":"30","author":"Guan","year":"2020","journal-title":"Thyroid"},{"issue":"8","key":"10.1016\/j.path.2021.05.011_bib27","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1002\/hed.25165","article-title":"Impact of oncogene panel results on surgical management of cytologically indeterminate thyroid nodules","volume":"40","author":"Valderrabano","year":"2018","journal-title":"Head Neck"},{"key":"10.1016\/j.path.2021.05.011_bib28","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12916-015-0419-z","article-title":"The variable phenotype and low-risk nature of RAS-positive thyroid nodules","volume":"13","author":"Medici","year":"2015","journal-title":"BMC Med"},{"issue":"8","key":"10.1016\/j.path.2021.05.011_bib29","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrg1656","article-title":"Telomeres and human disease: ageing, cancer and beyond","volume":"6","author":"Blasco","year":"2005","journal-title":"Nat Rev Genet"},{"issue":"4","key":"10.1016\/j.path.2021.05.011_bib30","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1158\/1541-7786.MCR-16-0003","article-title":"Understanding TERT promoter mutations: a common path to immortality","volume":"14","author":"Bell","year":"2016","journal-title":"Mol Cancer Res"},{"issue":"4","key":"10.1016\/j.path.2021.05.011_bib31","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1530\/ERC-13-0210","article-title":"Highly prevalent TERT promoter mutations in aggressive thyroid cancers","volume":"20","author":"Liu","year":"2013","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"10.1016\/j.path.2021.05.011_bib32","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1530\/ERC-14-0359","article-title":"Diagnostic and prognostic TERT promoter mutations in thyroid fine-needle aspiration biopsy","volume":"21","author":"Liu","year":"2014","journal-title":"Endocr Relat Cancer"},{"issue":"23","key":"10.1016\/j.path.2021.05.011_bib33","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1002\/cncr.29038","article-title":"Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm\/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay","volume":"120","author":"Nikiforov","year":"2014","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.path.2021.05.011_bib34","doi-asserted-by":"crossref","first-page":"E914","DOI":"10.1210\/jc.2012-3396","article-title":"RAS mutations in thyroid FNA specimens are highly predictive of predominantly low-risk follicular-pattern cancers","volume":"98","author":"Gupta","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.path.2021.05.011_bib35","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1089\/thy.2016.0583","article-title":"Noninvasive follicular thyroid neoplasm with papillary-like nuclear features accounts for more than half of \u201ccarcinomas\u201d harboring RAS mutations","volume":"27","author":"Paulson","year":"2017","journal-title":"Thyroid"},{"issue":"8","key":"10.1016\/j.path.2021.05.011_bib36","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1001\/jamaoncol.2016.0386","article-title":"Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors","volume":"2","author":"Nikiforov","year":"2016","journal-title":"JAMA Oncol"},{"issue":"6","key":"10.1016\/j.path.2021.05.011_bib37","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/cncr.22138","article-title":"Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity","volume":"107","author":"Liu","year":"2006","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.path.2021.05.011_bib38","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1089\/thy.2008.0303","article-title":"Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern)","volume":"19","author":"Rivera","year":"2009","journal-title":"Thyroid"},{"issue":"6","key":"10.1016\/j.path.2021.05.011_bib39","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/PAS.0b013e3181dbee07","article-title":"Encapsulated well-differentiated follicular-patterned thyroid carcinomas do not play a significant role in the fatality rates from thyroid carcinoma","volume":"34","author":"Piana","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.path.2021.05.011_bib40","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/modpathol.2010.112","article-title":"Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns","volume":"23","author":"Rivera","year":"2010","journal-title":"Mod Pathol"},{"issue":"8","key":"10.1016\/j.path.2021.05.011_bib41","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1001\/jamaoncol.2018.1446","article-title":"Change in diagnostic criteria for noninvasive follicular thyroid neoplasm with papillarylike nuclear features","volume":"4","author":"Nikiforov","year":"2018","journal-title":"JAMA Oncol"},{"issue":"6","key":"10.1016\/j.path.2021.05.011_bib42","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/modpathol.2017.9","volume":"30","author":"Cho","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2021.05.011_bib43","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.humpath.2018.06.033","article-title":"Exploration of BRAFV600E as a diagnostic adjuvant in the non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)","volume":"82","author":"Johnson","year":"2018","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.path.2021.05.011_bib44","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1089\/thy.2015.0227","article-title":"Histopathologic and clinical characterization of thyroid tumors carrying the BRAF(K601E) mutation","volume":"26","author":"Afkhami","year":"2016","journal-title":"Thyroid"},{"issue":"12","key":"10.1016\/j.path.2021.05.011_bib45","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1089\/thy.2019.0328","volume":"29","author":"Xu","year":"2019","journal-title":"Thyroid"},{"key":"10.1016\/j.path.2021.05.011_bib46","unstructured":"Guerrero D, Valderrabano P, Tarasova V, et\u00a0al. Clinical significance of TERT promoter and TP53 mutations in thyroid nodules with indeterminate cytology. Paper presented at: LABORATORY INVESTIGATION. 2020."},{"issue":"12","key":"10.1016\/j.path.2021.05.011_bib47","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/cncy.21802","article-title":"Young investigator challenge: molecular testing in noninvasive follicular thyroid neoplasm with papillary-like nuclear features","volume":"124","author":"Jiang","year":"2016","journal-title":"Cancer Cytopathol"},{"issue":"2","key":"10.1016\/j.path.2021.05.011_bib48","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00019606-199506000-00007","article-title":"Clonality of thyroid nodules in sporadic goiter","volume":"4","author":"Apel","year":"1995","journal-title":"Diagn Mol Pathol"},{"issue":"1","key":"10.1016\/j.path.2021.05.011_bib49","doi-asserted-by":"crossref","first-page":"15533","DOI":"10.1038\/ncomms15533","article-title":"The genetic landscape of benign thyroid nodules revealed by whole exome and transcriptome sequencing","volume":"8","author":"Ye","year":"2017","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.path.2021.05.011_bib50","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrc3431","article-title":"Molecular pathogenesis and mechanisms of thyroid cancer","volume":"13","author":"Xing","year":"2013","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.path.2021.05.011_bib51","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s004280050209","article-title":"Oncocytic tumours","volume":"433","author":"Tallini","year":"1998","journal-title":"Virchows Arch"},{"issue":"1","key":"10.1016\/j.path.2021.05.011_bib52","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12022-009-9102-2","article-title":"Oncocytes, oxyphils, H\u00fcrthle, and Askanazy cells: morphological and molecular features of oncocytic thyroid nodules","volume":"21","author":"Mete","year":"2010","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.path.2021.05.011_bib53","series-title":"WHO classification of tumours of endocrine organs","author":"Lloyd","year":"2017"},{"key":"10.1016\/j.path.2021.05.011_bib54","volume":"8","author":"DeLellis","year":"2004"},{"issue":"4","key":"10.1016\/j.path.2021.05.011_bib55","first-page":"555","article-title":"H\u00fcrthle cell lesions of the thyroid gland","volume":"139","author":"Thompson","year":"1974","journal-title":"Surg Gynecol Obstet"},{"issue":"4","key":"10.1016\/j.path.2021.05.011_bib56","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000133706","article-title":"Analysis of nuclear and mitochondrial DNA alterations in thyroid and renal oncocytic tumors","volume":"66","author":"Tallini","year":"1994","journal-title":"Cytogenet Cell Genet"},{"issue":"5","key":"10.1016\/j.path.2021.05.011_bib57","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0002-9440(10)61132-7","article-title":"Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on H\u00fcrthle cell tumors","volume":"160","author":"M\u00e1ximo","year":"2002","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.path.2021.05.011_bib58","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/1096-9896(200012)192:4<561::AID-PATH790>3.0.CO;2-3","article-title":"Mitochondrial DNA \u2018common\u2019 deletion in H\u00fcrthle cell lesions of the thyroid","volume":"192","author":"M\u00e1ximo","year":"2000","journal-title":"J\u00a0Pathol"},{"issue":"10","key":"10.1016\/j.path.2021.05.011_bib59","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1038\/sj.bjc.6602547","article-title":"Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (H\u00fcrthle cell) tumours of the thyroid","volume":"92","author":"M\u00e1ximo","year":"2005","journal-title":"Br J Cancer"},{"issue":"21","key":"10.1016\/j.path.2021.05.011_bib60","doi-asserted-by":"crossref","first-page":"9001","DOI":"10.1073\/pnas.0703056104","article-title":"Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors","volume":"104","author":"Gasparre","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.path.2021.05.011_bib61","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1530\/ERC-11-0354","article-title":"The biology and the genetics of Hurthle cell tumors of the thyroid","volume":"19","author":"M\u00e1ximo","year":"2012","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"10.1016\/j.path.2021.05.011_bib62","first-page":"547","article-title":"Frequent chromosomal DNA unbalance in thyroid oncocytic (H\u00fcrthle cell) neoplasms detected by comparative genomic hybridization","volume":"79","author":"Tallini","year":"1999","journal-title":"Lab Invest"},{"issue":"10","key":"10.1016\/j.path.2021.05.011_bib63","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1210\/jc.2002-020339","article-title":"Chromosomal aberrations by comparative genomic hybridization in Hu\u00a8rthle cell thyroid carcinomas are associated with tumor recurrence","volume":"87","author":"Wada","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.path.2021.05.011_bib64","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/00000478-200107000-00009","article-title":"Analysis of Hurthle cell neoplasms of the thyroid by interphase fluorescence in situ hybridization","volume":"25","author":"Erickson","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.path.2021.05.011_bib65","doi-asserted-by":"crossref","first-page":"e38287","DOI":"10.1371\/journal.pone.0038287","article-title":"Genome haploidisation with chromosome 7 retention in oncocytic follicular thyroid carcinoma","volume":"7","author":"Corver","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.path.2021.05.011_bib66","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/gcc.22194","article-title":"Near-haploidization significantly associates with oncocytic adrenocortical, thyroid, and parathyroid tumors but not with mitochondrial DNA mutations","volume":"53","author":"Corver","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"issue":"5","key":"10.1016\/j.path.2021.05.011_bib67","doi-asserted-by":"crossref","first-page":"E962","DOI":"10.1210\/jc.2012-3539","article-title":"Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy","volume":"98","author":"Ganly","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.path.2021.05.011_bib68","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ccell.2018.07.002","article-title":"Integrated genomic analysis of H\u00fcrthle cell cancer reveals oncogenic drivers, recurrent mitochondrial mutations, and unique chromosomal landscapes","volume":"34","author":"Ganly","year":"2018","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.path.2021.05.011_bib69","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ccell.2018.06.013","article-title":"Widespread chromosomal losses and mitochondrial DNA alterations as genetic drivers in H\u00fcrthle cell carcinoma","volume":"34","author":"Gopal","year":"2018","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.path.2021.05.011_bib70","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1002\/cncr.31245","article-title":"Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules","volume":"124","author":"Nikiforova","year":"2018","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.path.2021.05.011_bib71","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1001\/jamaoncol.2018.4616","article-title":"Performance of a multigene genomic classifier in thyroid nodules with indeterminate cytology: a prospective blinded multicenter study","volume":"5","author":"Steward","year":"2019","journal-title":"JAMA Oncol"},{"issue":"8","key":"10.1016\/j.path.2021.05.011_bib72","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/00000478-198708000-00001","article-title":"Hyalinizing trabecular adenoma of the thyroid gland","volume":"11","author":"Carney","year":"1987","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2021.05.011_bib73","first-page":"383","article-title":"PLAT: paraganglioma-like adenomas of the thyroid","volume":"1","author":"Bronner","year":"1988","journal-title":"Surg Pathol"},{"issue":"12","key":"10.1016\/j.path.2021.05.011_bib74","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1097\/PAS.0b013e31817a8f1b","article-title":"Hyalinizing trabecular tumors of the thyroid gland are almost all benign","volume":"32","author":"Carney","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.path.2021.05.011_bib75","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1097\/00000478-200012000-00005","article-title":"Hyalinizing trabecular tumor of the thyroid: a variant of papillary carcinoma proved by molecular genetics","volume":"24","author":"Cheung","year":"2000","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.path.2021.05.011_bib76","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1365-2559.1996.d01-432.x","article-title":"Hyalinizing trabecular carcinoma of thyroid gland","volume":"28","author":"McCluggage","year":"1996","journal-title":"Histopathology"},{"issue":"12","key":"10.1016\/j.path.2021.05.011_bib77","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1097\/00000478-200012000-00004","article-title":"RET\/PTC activation in hyalinizing trabecular tumors of the thyroid","volume":"24","author":"Papotti","year":"2000","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.path.2021.05.011_bib78","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1097\/00000478-200012000-00015","article-title":"Hyalinizing trabecular tumor of the thyroid: adenoma, carcinoma, or neoplasm of uncertain malignant potential?","volume":"24","author":"LiVolsi","year":"2000","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2021.05.011_bib79","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00125480-200201000-00002","article-title":"Hyalinizing trabecular tumors of the thyroid: a variant of papillary carcinoma?","volume":"9","author":"Lloyd","year":"2002","journal-title":"Adv Anat Pathol"},{"issue":"2","key":"10.1016\/j.path.2021.05.011_bib80","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/thy.2018.0791","article-title":"GLIS rearrangement is a genomic hallmark of hyalinizing trabecular tumor of the thyroid gland","volume":"29","author":"Nikiforova","year":"2019","journal-title":"Thyroid"},{"issue":"12","key":"10.1016\/j.path.2021.05.011_bib81","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1038\/s41379-019-0313-x","article-title":"PAX8-GLIS3 gene fusion is a pathognomonic genetic alteration of hyalinizing trabecular tumors of the thyroid","volume":"32","author":"Marchi\u00f2","year":"2019","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.path.2021.05.011_bib82","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1535-6108(02)00180-0","article-title":"Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma","volume":"2","author":"Tognon","year":"2002","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.path.2021.05.011_bib83","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/PAS.0b013e3181d9efcc","article-title":"Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity","volume":"34","author":"Skalova","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.path.2021.05.011_bib84","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1001\/jama.1966.03100050096033","article-title":"Breast carcinoma in children","volume":"195","author":"McDivitt","year":"1966","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.path.2021.05.011_bib85","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.5858\/arpa.2010-0351-RS","article-title":"Secretory breast carcinoma: unique, triple-negative carcinoma with a favorable prognosis and characteristic molecular expression","volume":"135","author":"Vasudev","year":"2011","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.path.2021.05.011_bib86","series-title":"World Health Organization classification of tumours: pathology and genetics of head and neck tumours","first-page":"177","article-title":"Secretory carcinoma","author":"Skalova","year":"2017"},{"issue":"10","key":"10.1016\/j.path.2021.05.011_bib87","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.humpath.2013.03.017","article-title":"Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma","volume":"44","author":"Bishop","year":"2013","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.path.2021.05.011_bib88","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/1066896916670005","article-title":"Combined DOG1 and mammaglobin immunohistochemistry is comparable to ETV6-breakapart analysis for differentiating between papillary cystic variants of acinic cell carcinoma and mammary analogue secretory carcinoma","volume":"25","author":"Said-Al-Naief","year":"2017","journal-title":"Int J Surg Pathol"},{"issue":"9","key":"10.1016\/j.path.2021.05.011_bib89","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/modpathol.2016.115","article-title":"Mammary analog secretory carcinoma of the thyroid gland: a primary thyroid adenocarcinoma harboring ETV6-NTRK3 fusion","volume":"29","author":"Dogan","year":"2016","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.path.2021.05.011_bib90","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s12105-016-0715-8","article-title":"A\u00a0case of primary mammary analog secretory carcinoma (MASC) of the thyroid masquerading as papillary thyroid carcinoma: potentially more than a one off","volume":"10","author":"Reynolds","year":"2016","journal-title":"Head Neck Pathol"},{"issue":"2","key":"10.1016\/j.path.2021.05.011_bib91","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12105-016-0741-6","article-title":"Mammary analog secretory carcinoma (MASC) involving the thyroid gland: a report of the first 3 cases","volume":"11","author":"Dettloff","year":"2017","journal-title":"Head Neck Pathol"},{"issue":"4","key":"10.1016\/j.path.2021.05.011_bib92","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/his.13268","article-title":"A\u00a0case of primary secretory carcinoma of the thyroid with high-grade features","volume":"71","author":"Wu","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2021.05.011_bib93","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3389\/fendo.2018.00555","article-title":"An unusual salivary gland tumor mimicking papillary thyroid carcinoma: mammary analog secretory carcinoma","volume":"9","author":"Asa","year":"2018","journal-title":"Front Endocrinol"},{"issue":"5","key":"10.1016\/j.path.2021.05.011_bib94","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/1066896917747076","article-title":"Mammary analogue secretory carcinoma of the thyroid mimicking locally advanced papillary thyroid carcinoma: a rare case report","volume":"26","author":"Liao","year":"2018","journal-title":"Int J Surg Pathol"},{"issue":"4","key":"10.1016\/j.path.2021.05.011_bib95","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s12105-018-0995-2","article-title":"Secretory carcinoma of the thyroid gland: report of a highly aggressive case clinically mimicking undifferentiated carcinoma and review of the literature","volume":"13","author":"Desai","year":"2019","journal-title":"Head Neck Pathol"},{"issue":"4","key":"10.1016\/j.path.2021.05.011_bib96","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/PAS.0000000000000814","article-title":"Clinical and morphologic features of ETV6-NTRK3 translocated papillary thyroid carcinoma in an adult population without radiation exposure","volume":"41","author":"Seethala","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.path.2021.05.011_bib97","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/s41379-020-0574-4","article-title":"Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC)","volume":"33","author":"Chu","year":"2020","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.path.2021.05.011_bib98","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/00000478-199105000-00003","article-title":"Sclerosing mucoepidermoid thyroid carcinoma with eosinophilia. A distinctive low-grade malignancy arising from the metaplastic follicles of Hashimoto's thyroiditis","volume":"15","author":"Chan","year":"1991","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.path.2021.05.011_bib99","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/modpathol.3800021","article-title":"p63 expression in sclerosing mucoepidermoid carcinomas with eosinophilia arising in the thyroid","volume":"17","author":"Hunt","year":"2004","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.path.2021.05.011_bib100","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.humpath.2015.01.012","article-title":"Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid: more aggressive than previously reported","volume":"46","author":"Quiroga-Garza","year":"2015","journal-title":"Hum Pathol"},{"issue":"6","key":"10.1016\/j.path.2021.05.011_bib101","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.anndiagpath.2003.09.002","article-title":"Clear cells and thyroid transcription factor I reactivity in sclerosing mucoepidermoid carcinoma of the thyroid gland","volume":"7","author":"Albores-Saavedra","year":"2003","journal-title":"Ann Diagn Pathol"},{"issue":"3","key":"10.1016\/j.path.2021.05.011_bib102","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/modpathol.2016.180","article-title":"Thyroid sclerosing mucoepidermoid carcinoma with eosinophilia: a clinicopathologic and molecular analysis of a distinct entity","volume":"30","author":"Shah","year":"2017","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.path.2021.05.011_bib104","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00401-011-0841-z","article-title":"Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody","volume":"122","author":"Capper","year":"2011","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1016\/j.path.2021.05.011_bib105","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s12105-020-01166-8","article-title":"Comparison of molecular methods and BRAF immunohistochemistry (VE1 Clone) for the detection of BRAF V600E mutation in papillary thyroid carcinoma: a meta-analysis","volume":"14","author":"Parker","year":"2020","journal-title":"Head Neck Pathol"},{"issue":"6","key":"10.1016\/j.path.2021.05.011_bib106","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/PAT.0000000000000119","article-title":"Immunohistochemistry with the anti-BRAF V600E (VE1) antibody: impact of pre-analytical conditions and concordance with DNA sequencing in colorectal and papillary thyroid carcinoma","volume":"46","author":"Dvorak","year":"2014","journal-title":"Pathology"},{"issue":"1","key":"10.1016\/j.path.2021.05.011_bib107","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.yexmp.2018.07.006","article-title":"Immunohistochemistry is a feasible method to screen BRAF V600E mutation in colorectal and papillary thyroid carcinoma","volume":"105","author":"Zhang","year":"2018","journal-title":"Exp Mol Pathol"},{"issue":"11","key":"10.1016\/j.path.2021.05.011_bib108","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1097\/PAS.0000000000000911","article-title":"Pan-Trk immunohistochemistry is an efficient and reliable screen for the detection of NTRK fusions","volume":"41","author":"Hechtman","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2021.05.011_bib109","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41379-018-0118-3","article-title":"Molecular characterization of cancers with NTRK gene fusions","volume":"32","author":"Gatalica","year":"2019","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.path.2021.05.011_bib110","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41379-019-0324-7","article-title":"NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls","volume":"33","author":"Solomon","year":"2020","journal-title":"Mod Pathol"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918121000453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918121000453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:43:10Z","timestamp":1761748990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918121000453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":109,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1875918121000453"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2021.05.011","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular Pathology of Thyroid Tumors","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2021.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}